An early-stage biotechnology company, Halide Biologics Inc personnel are structured around development of next-generation protein therapeutics using chemical biology approaches such as targeted fluorination to improve the stability, effectiveness, and pharmacological performance of recombinant protein drugs. Company management aim to create longer-lasting and more efficient biologic medicines for conditions like cancer and metabolic diseases, and it has received support through state-backed commercialization awards to advance its platform.
